Collin Price, MD

Board Certified
Psychiatry, American Board of Psychiatry and Neurology (ABPN)

Max Gray Fellow, Adult Mood Disorders Clinic
Semel Institute for Neuroscience and Human Behavior
David Geffen School of Medicine at UCLA, Los Angeles, CA

Collin M. Price, MD is a psychiatrist with clinical and research expertise in complex mood disorders, neuromodulation, and psychedelic-assisted psychotherapy. His work focuses on advancing innovative treatments for mood and trauma-related conditions, including participation in and leadership of clinical trials involving neuromodulation and MDMA-assisted psychotherapy for PTSD.

Dr. Price has played a key role in developing educational programming and scholarly initiatives in emerging areas of psychiatry, including founding the Psychedelic Psychiatry Interest Group at UCLA. A committed educator and investigator, he has published and presented nationally and internationally, and his contributions have been recognized with honors such as the ISCTM New Investigator Award.